Haemonetics reported $118.36M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Baxter International USD 730M 5M Sep/2026
Becton, Dickinson and Co. USD 1.26B 1000K Sep/2026
Boston Scientific USD 1.68B 120M Sep/2026
Cerus USD 19.33M 1.55M Dec/2024
Cooper Companies USD 401.3M 274.9M Jun/2026
Fresenius EUR 823M 63M Sep/2026
Fresenius Medical Care EUR 744M 7.99M Sep/2026
Globus Medical USD 288.47M 1.65M Sep/2026
Haemonetics USD 118.36M 580K Sep/2026
ICU Medical USD 154.41M 2.48M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
Medtronic 3.2B 141M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Neogen USD 100.8M 1000K Jun/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 4.26M 779K Mar/2026
Quidel USD 182.7M 7M Sep/2026
ResMed USD 290.65M 10.86M Jun/2026
STAAR Surgical USD 43.22M 1.92M Sep/2026
Steris USD 366M 3.7M Sep/2026
Stryker USD 2.12B 32M Jun/2026
Teleflex USD 220.72M 7.21M Sep/2026
Terumo JPY 109.58B 120M Sep/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
US Physical Therapy USD 17.83M 1.18M Sep/2026
Zimmer Biomet Holdings USD 855M 56.6M Sep/2026